• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

coronavirus treatment

Posted inCOVID-19, Infections, New Drugs, Regulatory

Xocova: Powerful New Japanese Pill for Coronavirus Treatment

by Nik Resovski and Timur Burkhanayev November 27, 2022December 5, 2022

Ensitrelvir by Shionogi & Co. is a highly effective antiviral drug that works just as well as Pfizer’s Paxlovid.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

by Mark Gubar June 8, 2022September 8, 2022

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

proxalutamide
Posted inClinical Trials, COVID-19, Infections

Kropsen: Strong New Pill to Treat COVID-19 Infection

by Julia Mardi April 11, 2022September 8, 2022

Oral proxalutamide by Chinese Kintor Pharmaceutical effectively treats COVID-19 in outpatients and inpatients.

Posted inClinical Trials, COVID-19, Infections, Research

Favipiravir to Treat COVID-19. Most Comprehensive Review in World

by Julia Mardi, Mark Gubar and Timur Burkhanayev March 5, 2022September 8, 2022

What benefit we should expect from favipiravir in the fight against coronavirus?

Posted inClinical Trials, COVID-19, Infections

Upamostat: Oral Medication for COVID-19

by Mark Gubar March 3, 2022September 8, 2022

Upamostat by RedHill Biopharma prevents COVID-19 complications from developing followed by hospitalization or death.

Posted inClinical Trials, COVID-19, Infections, Oncology

Yeliva: New Drug for COVID-19

by Tanya von Reuss and Timur Burkhanayev February 19, 2022September 8, 2022

Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.

nurse
Posted inClinical Trials, COVID-19, Infections

MesenCure: Israeli Miracle Drug Saves From Death by COVID-19

by Mark Gubar January 25, 2022September 8, 2022

A cell therapy developed by Bonus BioGroup is amazingly able to fight coronavirus and its most severe complications.

Posts pagination

1 2 3 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×